Skip to content

Press Releases

Date Title
May 18, 2020 Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research
May 4, 2020 Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development
Apr 30, 2020 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020
Apr 28, 2020 Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
Apr 16, 2020 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19
Apr 14, 2020 Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020
Feb 27, 2020 Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
Feb 12, 2020 Illumina to Webcast Upcoming Investor Conference Presentations
Feb 6, 2020 Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
Jan 29, 2020 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
Jan 13, 2020 Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020
Jan 13, 2020 Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics
Jan 13, 2020 Illumina and Roche Partner to Broaden Patient Access to Genomic Testing
Jan 10, 2020 Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
Jan 2, 2020 Illumina and Pacific Biosciences Announce Termination of Merger Agreement